Publications by Lorena Arranz
14 publications found
Publications 2025
-
Bone marrow sympathetic neuropathy is a hallmark of hematopoietic malignancies and it involves severe ultrastructural damage
14 (1), 31
DOI 10.1186/s40164-025-00614-x, PubMed 40045344
Publications 2023
-
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
14 (1), 12
DOI 10.1038/s41467-022-35700-9, PubMed 36596811 -
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
14 (1), 3874
DOI 10.1038/s41467-023-39601-3, PubMed 37391415
Publications 2022
-
The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
14 (3)
DOI 10.3390/cancers14030580, PubMed 35158848 -
Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells
11
DOI 10.7554/eLife.75908, PubMed 36052997
Publications 2021
-
Female Mice Reaching Exceptionally High Old Age Have Preserved 20S Proteasome Activities
Antioxidants, 10 (9), 1397
DOI 10.3390/antiox10091397 -
Accelerated immunosenescence, oxidation and inflammation lead to a higher biological age in COPD patients
Exp. Gerontol., 154, 111551
DOI 10.1016/j.exger.2021.111551
Publications 2020
-
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
8, 607
DOI 10.3389/fcell.2020.00607, PubMed 32754595
Publications 2019
-
Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche
8 (5)
DOI 10.3390/jcm8050707, PubMed 31109063
Publications 2018
-
Nestin-expressing progenitor cells: function, identity and therapeutic implications
Cell. Mol. Life Sci., 75 (12), 2177-2195
DOI 10.1007/s00018-018-2794-z -
Multiple faces of succinate beyond metabolism in blood
Haematologica, 103 (10), 1586-1592
DOI 10.3324/haematol.2018.196097 -
Updates on Old and Weary Haematopoiesis
Int. J. Mol. Sci., 19 (9), 2567
DOI 10.3390/ijms19092567 -
IL-1 beta Promotes a New Function of DNase I as a Transcription Factor for the Fas Receptor Gene
Front. Cell. Dev. Biol., 6, 7
DOI 10.3389/fcell.2018.00007
Publications 2017
-
Interleukin-1 beta as emerging therapeutic target in hematological malignancies and potentially in their complications
Blood Rev., 31 (5), 306-317
DOI 10.1016/j.blre.2017.05.001